Breaking News on Dairy Processing & Markets

News > Manufacturers

Read more breaking news



Arla to invest €12m in infant milk formula production

Post a comment

By Jim Cornall+


Arla is investing in its AKAFA facility in Svenstrup, northern Denmark.
Arla is investing in its AKAFA facility in Svenstrup, northern Denmark.

Arla is investing approximately €12m ($12.7m) to upgrade its AKAFA production site in northern Denmark, which will allow it to add infant milk formula (IMF) production to its existing powdered milk capacity. 

The investment will not require an expansion of the site, but consists of an upgrade of sections of the site to produce IMF.

Approximately 80% of the production at AKAFA is dedicated to powdered milk for family nutrition, and 20% is sterilized cream. The site’s products are sold in Latin America, Africa, Middle East and Asia.

The new IMF production at AKAFA is expected to start in August 2018, and will create two to four new jobs.

Arla sells IMF products under its own brands like Arla Baby & Me and Milex and is also a supplier to some third party brands. The biggest markets for Arla in the IMF category are China, Southeast Asia, Latin America and Europe.

Rising demand

Henrik Andersen, head of Arla Foods Ingredients, who is also responsible for Arla’s third party manufacturing (TPM) business, said the company is seeing double-digit growth in its global IMF sales, and expects the growth to continue in the coming years due to rising demand in the category worldwide.

Andersen told DairyReporter in China, Arla Food Ingredients sees some segments growing faster than others, with premium and super high premium segments being the ones to watch.

“In these segments our customers are looking for specific ingredients that would make their products unique,” Andersen said.

“And this is exactly what we like to develop, something that is unique and makes a difference in the end product.”

Andersen said, “What we particularly succeed with, in China in particular, but also other places, is the ability to fractionate whey proteins so that we can deliver specific fractions of the whey proteins that are particularly suited, for instance, in infant formula but also for medical purposes.”

Adult nutrition

He added the overall sports nutrition segment of performance nutrition is a huge market globally that is consuming around two thirds of all whey protein delivered to the market.

Andersen said adult nutrition for special medical purposes is also an area where Arla Food Ingredients can make a contribution.

“Some of what we do is driven by the way that we develop our technology in-house and what it can offer the market, and then we have a very good and close dialogue with customers and we say ‘this is something we can do, would it work for you in this application?’” he said.

“In infant formula, it's still the ambition to get as close as possible to human milk working from cow's milk, that's always, you could say, the dream, and we are pursuing that dream together with our customers.”               

Post a comment

Comment title *
Your comment *
Your name *
Your email *

We will not publish your email on the site

I agree to Terms and Conditions

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...